Skip to main content
Log in

Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis

  • Concise Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 7:R78–83

    Article  PubMed  Google Scholar 

  2. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011

    PubMed  Google Scholar 

  3. Kunin CM (1967) A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med 67:151–158

    CAS  PubMed  Google Scholar 

  4. MacKay DN, Kaye D (1964) Serum concentrations of colistin in patients with normal and impaired renal function. N Engl J Med 270:394–397

    CAS  PubMed  Google Scholar 

  5. Goodwin NJ, Friedman EA (1968) The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels. Ann Intern Med 68:984–994

    CAS  PubMed  Google Scholar 

  6. Package insert (2002) Coly-Mycin® M parenteral (colistimethate for injection, USP). Parkedale Pharmaceuticals, Rochester, MI, USA

  7. Hoeprich PD (1970) The polymyxins. Med Clin North Am 54:1257–1265

    CAS  PubMed  Google Scholar 

  8. Evans ME, Feola DJ, Rapp RP (1999) Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 33:960–967

    CAS  PubMed  Google Scholar 

  9. Curtis JR, Eastwood JB (1968) Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis. Br Med J 1:484–485

    PubMed  Google Scholar 

  10. Greenberg PA, Sanford JP (1967) Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate. Ann Intern Med 66:465–470

    CAS  PubMed  Google Scholar 

  11. Duncan DA (1973) Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis. Minn Med 56:31–35

    CAS  Google Scholar 

  12. Swick HM, Maxwell E, Charache P, Levin S (1969) Peritoneal dialysis in colistin intoxication: report of a case. J Pediatr 74:976–980

    CAS  PubMed  Google Scholar 

  13. Amsden GW (2000) Tables of antimicrobial agent pharmacology. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA, pp 578–579

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. C. Sarria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarria, J.C., Angulo-Pernett, F., Kimbrough, R.C. et al. Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis. Eur J Clin Microbiol Infect Dis 23, 340–341 (2004). https://doi.org/10.1007/s10096-004-1106-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-004-1106-8

Keywords

Navigation